financetom
Business
financetom
/
Business
/
MultiPlan Shares Fall After Q2 Loss Widens, Full-Year Revenue Outlook Cut
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MultiPlan Shares Fall After Q2 Loss Widens, Full-Year Revenue Outlook Cut
Aug 1, 2024 9:43 AM

12:14 PM EDT, 08/01/2024 (MT Newswires) -- MultiPlan ( MPLN ) shares were down about 18% in recent Thursday trading after the company reported a wider Q2 loss from a year ago and lowered its full-year revenue guidance.

The company reported a Q2 net loss of $0.89 per diluted share, compared with a loss of $0.06 a year earlier.

Two analysts polled by Capital IQ expected a loss of $0.05.

Revenue for the quarter ended June 30 fell to $233.5 million from $238 million a year earlier.

Two analysts surveyed by Capital IQ expected $248.6 million.

For Q3, the company expects revenue of $230 million to $245 million.

The consensus among two analysts is for $257.6 million.

For 2024, MultiPlan ( MPLN ) said it now expects revenue of $935 million to $955 million, down from $1 billion to $1.03 billion previously.

Two analysts polled by Capital IQ are looking for $1.01 billion.

Separately, the company said it has appointed Doug Garis as chief financial officer, effective Monday, succeeding Jim Head.

Garis most recently served as CFO of Oracle (ORCL) Health and Life Sciences, MultiPlan ( MPLN ) said, adding that Head will transition to a strategic adviser role to the company through the end of the year.

Price: 0.37, Change: -0.08, Percent Change: -17.91

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Santander to sell seven Pennsylvania branches to Community Bank
Santander to sell seven Pennsylvania branches to Community Bank
Jun 25, 2025
June 25 (Reuters) - Santander said on Wednesday it had agreed to sell seven branches in the Allentown, Pennsylvania area to U.S.-based Community Bank as the Spanish lender pivots towards becoming a digital-first bank in the United States. Santander launched Openbank in the U.S. market late last year with a high-yield savings account offering, and aims to have a full-service...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Easing Middle East Tensions
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Easing Middle East Tensions
Jun 25, 2025
08:32 AM EDT, 06/25/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.2% and the actively traded Invesco QQQ Trust (QQQ) was 0.3% higher in Wednesday's premarket activity as markets digest easing Middle East tensions. US stock futures were mixed, with S&P 500 Index futures up 0.1%, Dow Jones Industrial...
BRIEF-Minovia Therapeutics And Launch One Acquisition Announce JV To Create Mitochondrial Therapy Company
BRIEF-Minovia Therapeutics And Launch One Acquisition Announce JV To Create Mitochondrial Therapy Company
Jun 25, 2025
June 25 (Reuters) - Launch One Acquisition Corp ( LPAA ) : * MINOVIA THERAPEUTICS LTD. AND LAUNCH ONE ACQUISITION CORP. ( LPAA ) ANNOUNCE PROPOSED BUSINESS COMBINATION TO CREATE NASDAQ-LISTED MITOCHONDRIAL THERAPY COMPANY IN $1 TRILLION+ MITOCHONDRIAL AND LONGEVITY MARKETS * MINOVIA THERAPEUTICS - COMBINED ENTITY TO OPERATE AS MITO US ONE LTD. ON NASDAQ * MINOVIA THERAPEUTICS -...
Copyright 2023-2026 - www.financetom.com All Rights Reserved